Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2020-06-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于全资子公司取得土地使用权证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the acquisition of land use rights by a wholly-owned subsidiary of the company. It details the transaction overview, land specifics, purpose, and impact on the company. There are no financial statements or detailed financial performance data included. The document is relatively short (1377 characters) and serves as a formal disclosure of a corporate transaction rather than a financial report or detailed management discussion. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-06-18 Chinese
关于非公开发行股票限售股份解除限售的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from a listed company regarding the lifting of restrictions on previously non-publicly issued shares, allowing these shares to be freely traded on the stock exchange. It details the number of shares involved, the shareholders affected, the dates of restriction lifting, and compliance with regulatory requirements. The document references approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules, and includes tables showing shareholding changes and shareholder commitments. The content focuses on share capital structure changes and the listing status of shares, without presenting financial statements or earnings data. The document length is 3214 characters, which is relatively short and typical for a regulatory announcement rather than a full report. This fits the definition of a Share Issue/Capital Change announcement, specifically about the removal of lock-up restrictions on shares, which is a capital structure change. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2020-05-24 Chinese
中德证券有限责任公司关于公司非公开发行限售股解禁上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Zhongde Securities regarding the unlocking and listing of restricted shares from a non-public issuance by Qidi Guhan Group Co., Ltd. It details the background of the non-public issuance, the number of shares being unlocked, the shareholders involved, and compliance with regulatory requirements. The document is focused on the approval and verification of the lifting of restrictions on shares for trading, including compliance with securities regulations and shareholder commitments. It is not a financial report, earnings release, or management discussion, but rather a regulatory compliance and verification statement related to share unlocking and circulation. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory compliance announcement and verification opinion rather than a financial report or capital change announcement. The document length is 3057 characters, which is relatively short and focused on regulatory verification rather than a full report or announcement of a report publication.
2020-05-24 Chinese
第九届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the ninth Supervisory Board of the company. It details the election of the Supervisory Board Chairman and includes attendance and voting results. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a formal announcement related to board/management changes, specifically about the Supervisory Board leadership. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on governance changes, not a full report or regulatory filing.
2020-05-21 Chinese
第九届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors regarding the appointment of senior management and their remuneration plan. It references compliance with company law, governance codes, and internal procedures. It does not contain financial statements or detailed financial results, nor is it a report or announcement of voting results. It is related to management appointments and remuneration approval, which fits best under Board/Management Information (MANG). The document length is short and focused on management matters, not a full report or announcement of a meeting result.
2020-05-21 Chinese
公司章程（2020年5月）
Governance Information Classification · 100% confidence The document is a detailed company charter (章程) for 启迪古汉集团股份有限公司, including comprehensive sections on company governance, shareholder rights, board structure, and operational rules. It references multiple shareholder meetings where amendments were approved, and it extensively covers the internal rules and governance practices of the company. There is no indication that this is an announcement or a summary; rather, it is the full text of the company's articles of association or bylaws. This type of document fits the definition of Governance Information (CGR), which details the company's internal rules, board structure, and governance practices.
2020-05-21 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.